R

Rezo Therapeutics

Maps disease networks to precision therapies

Vice President, Finance and Administration

Corporate Finance & FP&AConfirmed live in the last 24 hours
Full-timeSan Francisco, CA, USAIn-person

About the Job

Requirements

  • Demonstrated success supporting Series A, Series B, Series C, or later fundraising efforts, and owning financial storytelling, diligence, and investor communications; IPO experience is a plus.
  • At least 10 years of progressive finance experience, including at least 5 years leading finance and administration at a venture-backed biotech; experience through the transition from development candidate into IND-enabling studies and early clinical development is ideal.
  • Hands-on experience building operating plans, research and development program budgets, and cash runway models tied to research and development milestones, and supporting venture capital financing rounds, including investor diligence and board reporting.
  • Experience implementing or overseeing accounting and other finance functions, such as accounts payable and procurement.
  • Deep strategic finance experience, including long-range planning, portfolio modeling, research and development cost structures, and scenario-based forecasting.
  • Experience overseeing cross-functional operational teams and administrative functions.
  • Experience in fundraising and financing.
  • Ability to move between strategic vision and hands-on execution.
  • Ability to communicate complex matters clearly to investors, board members, and internal teams.
  • Strong judgment and integrity.
  • A bachelor's degree in Finance, Accounting, Business, or a related field is required.

Responsibilities

  • Lead long-range financial planning and scenario modeling to support the research pipeline and company growth, partnering with the CEO and business leadership on capital strategy, financing alternatives, and valuation.
  • Partner with the CEO on fundraising by preparing materials, managing due-diligence processes, shaping the financial storyline, and building investor relationships.
  • Partner with the CEO on ongoing investor relations, including investor outreach, meetings, and communications.
  • Own budgeting, forecasting, cash management, and financial reporting.
  • Oversee accounting, audits, tax, compliance, procurement, and internal controls.
  • Build and maintain financial planning and reporting tools that provide visibility into program-level budgets, actual spend, committed expenditures, and forecast-to-complete, enabling resource allocation and cash runway management.
  • Oversee core administrative functions, including information technology, facilities, and real estate, to ensure reliable and efficient operations supporting scientific progress.
  • Partner with scientific and corporate teams to anticipate resource and infrastructure needs and implement scalable processes that enable their work and remove operational obstacles.
  • Foster a culture of accountability, clarity, and strategic resource stewardship.

Desired Qualifications

  • Experience in a platform biotech or technology- or artificial intelligence-driven drug discovery company.
  • Initial public offering experience.
  • A Master of Business Administration, Certified Public Accountant, Chartered Financial Analyst, or other relevant advanced training.

About the Company

Rezo Therapeutics

Maps disease networks to precision therapies

Rezo Therapeutics maps disease networks to develop precision medicines using its SSD platform, which integrates proteomics, genetics, structural biology, chemistry, and bioinformatics to build networks of molecular interactions in diseases. The platform analyzes protein‑protein and genetic interactions to identify druggable targets that traditional target‑driven methods might miss, with an initial focus on solid tumor oncology and partnerships for other areas. It differentiates itself by combining high‑level biology with computational network biology in one platform to map whole disease networks rather than chasing single targets, supported by leadership rooted in UCSF’s QBI. The company aims to translate network discoveries into targeted therapies and grow its pipeline through collaborations and strategic partnerships.

Company size
11-50
Company stage
Series A
Total funding
$78M
Headquarters
San Francisco, CA
Founded
2021

Recently Posted Jobs

Explore more opportunities at Rezo Therapeutics

See more jobs